Mutations in KEAP1, hypoxic environment, along with epigenetic and post-translational alterations, lead to persistent NRF2 activation, enhancing cancer cells’ antioxidant capabilities and metabolic flexibility (16). This evidence concerns the gene KEAP1 and cancer.